Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Mizuho analyst Steven Valiquette raised the firm’s price target on Henry Schein (HSIC) to $78 from $75 and keeps a Neutral rating on the ...
Shares of Henry Schein Inc. advanced 4.95% to $79.87 Wednesday, on what proved to be an all-around poor trading session for ...
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...